ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)
South Korea flag South Korea · Delayed Price · Currency is KRW
981.00
-57.00 (-5.49%)
At close: Feb 13, 2026

KOSDAQ:034940 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
1,1192,0972,0474,5265,7494,164
Short-Term Investments
195.642,5491,5381,5371,5871,706
Trading Asset Securities
-800.73775.022,3862,8493,176
Cash & Short-Term Investments
1,3155,4474,3618,44910,1849,046
Cash Growth
-78.70%24.93%-48.39%-17.04%12.59%-37.57%
Accounts Receivable
17,98318,25020,23022,72720,88421,546
Other Receivables
2,2901,8182,5932,7312,3592,024
Receivables
20,73220,94823,90027,60324,86725,039
Inventory
12,92312,44613,01210,86910,28612,581
Prepaid Expenses
-204.8887.4594.42118.886.24
Other Current Assets
655693.01796.441,1831,048597.9
Total Current Assets
35,62539,74042,15748,20046,50447,350
Property, Plant & Equipment
20,02919,71220,37024,99924,07422,190
Long-Term Investments
3,0693,0682,7922,9353,6783,163
Goodwill
----46.7846.78
Other Intangible Assets
715.18769803.4806.87795.5583.5
Long-Term Accounts Receivable
-01,0541,054--
Long-Term Deferred Tax Assets
1,3031,3701,4991,401945.321,671
Other Long-Term Assets
6,2056,6625,5446,0284,0496,377
Total Assets
69,44671,32074,22185,63980,51282,377
Accounts Payable
4,3104,8655,5014,9943,6853,599
Accrued Expenses
-3,5163,4942,7652,7752,664
Short-Term Debt
22,15020,75014,55014,55412,7944,450
Current Portion of Long-Term Debt
902.39448.61---3,700
Current Portion of Leases
661.41629.07633.15637.5684.07745.25
Current Unearned Revenue
-140.5153.42122.2788.1125.71
Other Current Liabilities
9,0506,3064,8474,2554,2363,894
Total Current Liabilities
37,07336,65629,17827,32824,26319,178
Long-Term Debt
2,2011,5761,1051,9041,000-
Long-Term Leases
1,8841,2851,2131,5831,9961,350
Pension & Post-Retirement Benefits
2,0331,301545.82-1,3281,491
Other Long-Term Liabilities
1,8951,9413,4223,4173,5423,615
Total Liabilities
45,08542,75935,46434,23132,12925,634
Common Stock
15,49015,49015,49015,49015,49015,490
Additional Paid-In Capital
63,62163,62163,62163,62163,62163,502
Retained Earnings
-51,559-47,817-38,175-26,354-29,255-20,640
Comprehensive Income & Other
76.8681.6757.0786.2964.05-50.28
Total Common Equity
27,62931,37640,99352,84449,92058,302
Minority Interest
-3,268-2,815-2,235-1,436-1,537-1,559
Shareholders' Equity
24,36128,56138,75851,40848,38356,743
Total Liabilities & Equity
69,44671,32074,22185,63980,51282,377
Total Debt
27,79824,68917,50118,67816,47410,245
Net Cash (Debt)
-26,484-19,242-13,141-10,229-6,289-1,199
Net Cash Per Share
-853.43-621.10-424.17-330.17-203.02-38.71
Filing Date Shares Outstanding
30.9830.9830.9830.9830.9830.98
Total Common Shares Outstanding
30.9830.9830.9830.9830.9830.98
Working Capital
-1,4483,08412,97920,87222,24228,172
Book Value Per Share
891.831012.781323.221705.751611.381881.94
Tangible Book Value
26,91430,60740,19052,03749,07857,672
Tangible Book Value Per Share
868.75987.961297.291679.701584.201861.59
Land
8,8118,8118,8649,4089,3297,060
Buildings
3,32814,75614,73918,17818,12917,637
Machinery
4,79530,69330,23326,89326,80727,563
Construction In Progress
473.04-7.244,1571,430191.73
Source: S&P Global Market Intelligence. Standard template. Financial Sources.